CureVac AG has stressed that it knew nothing of any offers from the White House for its coronavirus vaccine candidate after a fevered few days for the German biotech firm that have seen two changes of CEO, as it found itself at the center of a media storm in the midst of a pandemic.
“There is no takeover offer from the White House or governmental authorities neither to the technology or to CureVac as a company,” said acting CEO Franz Werner-Haas during a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?